TAM
ALNA

Tiverton Asset Management’s Allena Pharmaceuticals ALNA Stock Holding History

Tiverton Asset Management’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4,546
Closed -$18K – 749
2019
Q2 		$18K Hold
4,546
– – ﹤0.01% 679
2019
Q1 		$32K Buy
4,546
+132
+3% +$957 ﹤0.01% 640
2018
Q4 		$24K Buy
+4,414
New +$38.1K ﹤0.01% 480

Other funds holding ALNA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Tiverton Asset Management's ALNA Position: Q3 2019 in Review

Tiverton Asset Management sold out of Allena Pharmaceuticals (ALNA) in Q3 2019, closing a stake of 4,546 shares — an estimated $18K sold.

Tiverton Asset Management first reported a position in ALNA in Q4 2018 and held it in 3 quarters. The position peaked at $32K in Q1 2019. 35 funds tracked by Wall St. Rank hold ALNA as of Q3 2019.

  • Tiverton Asset Management reported no remaining Allena Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Tiverton Asset Management sold 4,546 Allena Pharmaceuticals shares in Q3 2019, an estimated $18K.
  • Tiverton Asset Management first reported a position in Allena Pharmaceuticals in Q4 2018 and held it in 3 quarters.
  • Tiverton Asset Management's Allena Pharmaceuticals position peaked at $32K in Q1 2019.
  • 35 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.